NeuroLife today launched as a non-invasive neurotechnology company developing wearable solutions to support rehabilitation for people affected by stroke or spinal cord injury.
NeuroLife is the market-facing brand of ActivateNeuro and is established through a strategic partnership between Battelle and The NeuroTech Institute (NTI).
NeuroLife is a wearable sleeve that reads electrical signals from muscles and nerves, interprets movement intent and delivers targeted stimulation to support functional hand and arm recovery during guided therapy. The platform integrates high-density neuromuscular sensing, intelligent decoding and adaptive stimulation translating neuromuscular signals into real-time feedback to support personalized, signal-driven rehabilitation.
"NeuroLife represents a focused step forward in how rehabilitation can evolve," said Jon Snyder, CEO of NeuroLife. "Our goal is to develop a non-invasive platform that supports functional hand and arm use by making therapy more personalized, responsive and aligned with how the body naturally moves."
"Battelle has a long history of translating scientific innovation into real-world impact," said Matt McFarland, Vice President of Commercial Strategy at Battelle. "Our collaboration with NTI and the formation of NeuroLife advances neurotechnology from foundational research into clinical and commercial development. NeuroLife brings the rigor of Battelle's research capabilities into a platform built for clinical environments and patient impact."
Built as a flexible system, the platform is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions. Its wearable, non-invasive design is intended to support accessibility, ease of use and integration into clinical workflows.
